Xenon Pharmaceuticals Inc.

(XENE) Trade

By |

Profile

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its products portfolio includes Glybera, TV-45070.

Contact Information

Website: www.xenon-pharma.com
Email: investors@xenon-pharma.com
Main Phone: +1 604 484-3300
Address: 200-3650 Gilmore Way
State: BC
City / Town: Burnaby
Country: CAN
Postal Code: V5G 4W8

Issuer Information

Exchange: NSD
CEO: Simon Pimstone
Employees: 81
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 10.05 $ -0.05 (-0.50%)
Last Price 10.05 Change $ -0.05 Change % -0.50 Tick N/A
Bid 8.80 Bid Size 2,000.00 Ask 10.85 Ask Size 1,000.00
Open 10.15 High 10.45 Low 9.93 Prev Close 10.10
Last Trade Volume 55,939 52 Wk Hi 11.00 52 Wk Low 2.10
Market Cap 177.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 17,658,292.00 EPS (TTM) -1.50 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 42
Number of Buys 1 35
Number of Sells 4 7
Net Activity -2431626 -2092506
Last 10 Buys Shares
Mohammad Azab 1,000
Mohammad Azab 1,000
Mohammad Azab 1,000
Mohammad Azab 1,000
Raymond J. Winquist 1,000
Mohammad Azab 1,000
James R. Empfield 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Michael Hayden 1,000
Last 10 Sell Shares
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Y. Paul Goldberg 1,000
Y. Paul Goldberg 1,000
Y. Paul Goldberg 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 9
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 9 9 9 9
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/16/18 05/16/18 05/16/18 05/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1